Latest filing published 24 Jun 2019 for AIM ImmunoTech Inc., €19k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -78.6%Entry US$1,280.31 · Close at T+365 US$273.52
- -52.9%Entry US$2,902.04 · Close at T+365 US$1,365.66
- +0.0%Entry US$2,091.17 · Close at T+365 US$2,091.17
- -31.0%Entry US$29,703.20 · Close at T+365 US$20,484.97
- -12.5%Entry US$28,678.95 · Close at T+365 US$25,094.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wayne S. Springate: trading record in brief
Wayne S. Springate is a declared insider of AIM ImmunoTech Inc., with filings sourced from SEC (Form 4). We count 18 filings; the first trade dates from 31 January 2009 and the latest from 21 June 2019.
Market trades split into 7 purchases (€133k) and 1 sale (€40k). Purchases outweigh sales by €93k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 share grants. So far in 2019, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €8,552. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 40% of cases, with a median move of -8.6%. These figures describe past trades and do not predict future prices.
The latest filing, published on 24 June 2019, reports an open-market purchase of €19k in AIM ImmunoTech Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Wayne S. Springate
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,211 shares@ US$4.03Common StockSEC:0001191434-19-000005:0Canonical exit: 19 Sept 2019 (T+90)
- 50,000 sharesCommon StockSEC:0001613377-19-000006:0
- 35,000 sharesCommon StockSEC:0001613377-19-000006:1
- 10 sharesSeries B Convertible Preferred StockSEC:0001583701-19-000003:0
- 50,000 sharesWarrantsSEC:0001583701-19-000003:1
- 2,500 shares0Common StockSEC:0001613377-18-000034:0
- 32,259 shares@ US$0.31100.0% of flowCommon StockSEC:0001613377-18-000019:0Canonical exit: 21 Oct 2018 (T+90)
- 15,873 shares@ US$0.6372.5% of flowCommon StockSEC:0001465652-17-000001:0Canonical exit: 31 Jul 2017 (T+90)
- 8,014 shares@ US$0.4627.5% of flowCommon StockSEC:0001613377-17-000004:0Canonical exit: 17 May 2017 (T+90)
- 185,748 shares@ US$0.591Common StockSEC:0001465652-10-000001:0Canonical exit: 13 Sept 2010 (T+90)
- 83,104 shares@ US$0.591Common StockSEC:0001465652-10-000001:1
- 877 shares@ US$0.5622Common StockSEC:0001465652-09-000003:0Canonical exit: 15 Mar 2010 (T+90)
- 46,473 shares@ US$0.13Incentive sharesSEC:0001465652-09-000002:0
- 42,789 shares@ US$0.15Incentive sharesSEC:0001465652-09-000002:1
- 44,172 shares@ US$0.14Incentive sharesSEC:0001465652-09-000002:2
- 35,427 shares@ US$0.18Incentive sharesSEC:0001465652-09-000002:3
- 16,887 shares@ US$0.37Incentive sharesSEC:0001465652-09-000002:4
17 of 17 declarations